WednesdayDec 27, 2006 5:47 pm

MNCL – Martin Nutraceuticals, Inc. Features Treatment for Arthritis

The Martin Nutraceuticals signature product for the treatment of Arthritis is Arthrizyme.  Arthrizyme differs from all other natural arthritis remedies. Arthrizyme was designed to work for all types of arthritis and in all joints of the body. Arthrizyme will rid the body of inflammation regardless of location and promote healing. Arthrizyme is fast acting, usually improving symptoms within the first few days. Arthrizyme is a systemic oral enzyme designed to revolutionize the way arthritis is naturally treated. According to Time Magazine, we are in the age of arthritis. The Center for Disease Control (CDC) estimates that 1 in 3 Americans have arthritis…

Continue Reading

TuesdayDec 26, 2006 1:56 pm

Martin Nutraceuticals, Inc. Rebounds After Holiday, Up 50%

Investors went shopping on the day after Christmas, and sent the shares of MNCL - Martin Nutraceuticals Up 50% for the day. Over the past decade, MNCL has developed a large family of complimentary medicine products, that have been well received by consumers.  The product uses span general joint pain, increased activity of the immune system, alertness and awareness, and obesity control.

Continue Reading

WednesdayDec 06, 2006 12:58 pm

Small Cap Stock Newsletter QualityStocks New Site Launched

SCOTTSDALE, AZ. Small Cap Stock Newsletter QualityStocks.net has been tracking hundreds of investment newsletters since January and this week “The NEW QualityStocks.net Daily Newsletter” was delivered with great results. “Our NEW web site launched on schedule December 1st and the comments we have received to far have been outstanding.” stated Michael McCarthy, Director of Business Development with QualityStocks.net. The following stocks were featured this week in The NEW QualityStocks.net Daily Newsletter: Military Resale Group, Inc. (MYRG) was highlighted this month by SmallCapVoice, Traders Nation, and QualityStocks.net. Military Resale Group has a solid track record as a specialist in military distribution and following the acquisition of Pittock Distributors…

Continue Reading

TuesdayDec 05, 2006 6:04 pm

Study Points to Problems with Arthritis Pharmaceuticals

Martin Nutraceuticals Inc. (MNCL) cites a recent Canadian press article on Prexige, a member of the same drug class as Vioxx gaining Health Canada approval. Prexige is also a Cox-2 inhibitor which has been brought to market as a treatment for new acute and chronic pain due to osteoarthritis of the knee in adults. This Cox-2 inhibitor is from the same class of drugs that were recently pulled from the market worldwide after studies showed people on the drug were almost double the risk of heart attack and stroke than non-users of these drugs, namely - Vioxx, Celebrex and Bextra.…

Continue Reading

FridayDec 01, 2006 3:59 pm

Martin Nutraceuticals (MNCL) to Launch Infomercials

The Company plans to benefit from an aggressive direct product marketing campaign to launch shortly. "We are now in the final stretch of completing our corporate objective, which has been penetrating the multi-billion dollar DRTV market. Many companies have strived to accomplish a complete DRTV program, Martin Nutraceuticals is one of the few companies that has achieved this milestone. We will use this DRTV program as a launching pad that will put us in the forefront of the Nutraceutical market," states Harvey Panesar, President of Martin Nutraceuticals Inc.

Continue Reading

FridayDec 01, 2006 3:48 pm

MNCL Finds Huge Global Niche in Health and Wellness

Martin Nutraceuticals brings a broad range of products to the market, for disorders that affect millions of people worldwide. With the aging of the population and the increasing importance that consumers give to their health, the US and European market will grow tremendously. Some studies have calculated that the annual market will reach $60 billion by 2009. New research shows that Pine Bark Extract as used by MNCL Martin Nutraceuticals in its products has positive effects on the Cardiovascular System. It shows to lower blood pressure, reduce LDL cholesterol, improve microcirculation, and prevent platelet aggregation.

Continue Reading

FridayDec 01, 2006 3:45 pm

Dr. Martin’s New Book is Really on Target

Dr. Tony Martin, Director of Research and Development with Martin Nutraceuticals (MNCL), was a featured speaker recently at the “Whole Life Expo” in Toronto to a “standing room only” crowd. Dr. Martin introduced his latest book at the event; “Medical Crisis: Secrets Your Doctor Won’t Share With You”. The event is Canada’s largest showcase of natural health and alternative medicine. The book provides great insights into the health benefits of the Company's flagship products, Arthrizyme and Oxygenol. The book and the products will be featured in upcoming infomercials to launch in the near future. Direct Response Television has been proven…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered